Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Cell Carcinoma, Clear Cell Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02387307
What this trial is testing

RSIFN-co in Subjects With Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungCarcinoma, Renal CellMelanoma+2 more
Sichuan Huiyang Life Science and Technology Corporation 42
Testing effectiveness (Phase 2)Study completedNCT00918281
What this trial is testing

Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection

Who this might be right for
Solid TumorsHigh Grade GliomasLung Cancer+4 more
GE Healthcare 70
Early research (Phase 1)Looking for participantsNCT05518253
What this trial is testing

A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

Who this might be right for
Metastatic TumorAdvanced Solid TumorRenal Cell Carcinoma+2 more
Weijia Fang, MD 30
Large-scale testing (Phase 3)Study completedNCT02883153
What this trial is testing

Zirconium-89-girentuximab PET/CT Imaging in Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Radboud University Medical Center 30
Early research (Phase 1)Study completedNCT00199875
What this trial is testing

Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric G250

Who this might be right for
Renal Cell CarcinomaKidney NeoplasmRenal Cancer+1 more
Ludwig Institute for Cancer Research 18
Testing effectiveness (Phase 2)Study completedNCT04704219
What this trial is testing

Pembrolizumab Plus Lenvatinib for First-line Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (1L nccRCC) (MK-3475-B61)

Who this might be right for
Renal Cell Carcinoma
Merck Sharp & Dohme LLC 160
Early research (Phase 1)UnknownNCT05843305
What this trial is testing

BPI-452080 in Subjects With Solid Tumors

Who this might be right for
Solid TumorRenal Cell CarcinomaVon Hippel-Lindau Disease
Betta Pharmaceuticals Co., Ltd. 87
Early research (Phase 1)Not Yet RecruitingNCT07770802
What this trial is testing

Clinical Study of HS-IT101 Injection in the Treatment of Advanced Renal Cancer

Who this might be right for
Clear Cell Renal Cell Carcinoma
Qingdao Sino-Cell Biomedicine Co., Ltd. 15
Large-scale testing (Phase 3)Active Not RecruitingNCT03873402
What this trial is testing

Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Participants With Advanced Kidney Cancer

Who this might be right for
Renal Cell Carcinoma
Bristol-Myers Squibb 437
Very early researchStudy completedNCT04028245
What this trial is testing

Combination Spartalizumab and Canakinumab in Patients With Localized Clear Cell Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Columbia University 17
Early research (Phase 1)UnknownNCT04142931
What this trial is testing

Sequentional Immuno Apheresis Plasma Volume Escalation Cohort Study of Reduction of Soluble Tumor Necrosis Factor Receptors 1 and 2 (sTNFR1/2) With or Without Nivolumab in Patients With Inoperable or Metastatic Solid Tumors

Who this might be right for
Stage IV Non-small Cell Lung CancerStage IV MelanomaTriple Negative Breast Cancer+1 more
Dr. Ronnie Shapira 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT06146777
What this trial is testing

Multi-classifier System for Stratifying Stage III Papillary Renal Cell Carcinoma of Receiving Adjuvant Therapy

Who this might be right for
Papillary Renal Cell Carcinoma
First Affiliated Hospital, Sun Yat-Sen University 468
Very early researchStudy completedNCT01666353
What this trial is testing

PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy

Who this might be right for
MelanomaRenal Cell Carcinoma (RCC)Non-small Cell Lung Cancer (NSCLC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Large-scale testing (Phase 3)Looking for participantsNCT07383441
What this trial is testing

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+1 more
SWOG Cancer Research Network 718
Early research (Phase 1)Looking for participantsNCT06582017
What this trial is testing

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

Who this might be right for
Ovarian CancerPancreas CancerUrothelial Carcinoma+6 more
Nammi Therapeutics Inc 100
Not applicableStudy completedNCT01028638
What this trial is testing

Vascular Endothelial Growth Factor (VEGF) Imaging Before and During Everolimus Treatment for Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
University Medical Center Groningen 13
Not applicableStudy completedNCT02315755
What this trial is testing

Observational Study Evaluating The Efficacy And Effects On Quality Of Life Of Targeted Treatments Following TKIs In mRCC

Who this might be right for
Renal Cell Carcinoma
Pfizer 102
Not applicableUnknownNCT03667885
What this trial is testing

Non-Invasive Diagnostics of Small Renal Masses

Who this might be right for
Renal Cell CarcinomaRenal Tumor
Odense University Hospital 160
Testing effectiveness (Phase 2)Looking for participantsNCT07636785
What this trial is testing

And 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors

Who this might be right for
Hepatocellular Carcinoma (HCC)Metastatic Uveal MelanomaRenal Cell Carcinoma (RCC)+2 more
VM Discovery, Inc. 111
Testing effectiveness (Phase 2)Looking for participantsNCT05327686
What this trial is testing

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Who this might be right for
Metastatic Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8Stage IV Renal Cell Cancer AJCC v8+1 more
NRG Oncology 240
Next Page